OptimizeRx Reports Third Quarter 2023 Financial Results
November 06, 2023 07:00 ET
|
OptimizeRx Corporation
- Increases guidance for 2023 and introduces guidance for 2024- Total revenue of $16.3 million- GAAP net loss per share of $(0.17)- Non-GAAP net income per share of $0.09- Total DAAP (fka RWD) deals...
OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET
October 25, 2023 07:30 ET
|
OptimizeRx Corporation
WALTHAM, Mass., Oct. 25, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and...
OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers
October 12, 2023 07:00 ET
|
OptimizeRx Corporation
Preannounces Preliminary Third Quarter 2023 Results OptimizeRx adds new, proven, profitable technologies to become the most comprehensive healthcare marketing platform in the nation. Consolidated...
OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform
September 26, 2023 08:00 ET
|
OptimizeRx Corporation
WALTHAM, Mass., Sept. 26, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and...
OptimizeRx Expands AI Powered Omnichannel Platform
August 24, 2023 08:00 ET
|
OptimizeRx Corporation
WALTHAM, Mass., Aug. 24, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Reports Second Quarter 2023 Financial Results
August 14, 2023 16:01 ET
|
OptimizeRx Corporation
– RWD.AI-enabled portion of the core business sees 186% YOY growth during the first half of 2023 – Non-core business is lagging – Total revenue of $13.8 million – GAAP net loss...
OptimizeRx Sets Second Quarter 2023 Conference Call for August 14, 2023 at 4:30 p.m. ET
July 31, 2023 08:01 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., July 31, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx’s CEO Provides 2023 Midyear Strategic Update
May 24, 2023 07:30 ET
|
OptimizeRx Corporation
A leading suite of pharma tech solutions combined with deep brand penetration is driving revenue growth, resulting in improved profitability and KPIs through the remainder of 2023 and beyondWith a...
OptimizeRx’s Karina Castagna Named One of the 2023 PM360 ELITE 100
May 18, 2023 08:01 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., May 18, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx to Participate in Upcoming Investor Conferences
May 15, 2023 08:00 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., May 15, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...